|1||Not yet recruiting||
Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
A Phase III Study to Evaluate the Efficacy and Safety of BAY 1192631 in Japanese Patients With MRSA Infections (SSTI and SSTI-related Bacteremia).
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
TR-701 FA vs Linezolid for the Treatment of Nosocomial Pneumonia
† Indicates status has not been verified in more than two years